1. An Overview of Adverse Drug Reaction Monitoring in China

   • Yibing Zhou
   • Victor Miller
   • Larry Callahan

   Current Opinion 24 August 2012 Pages: 79 - 85

   

2. Decomposing the Value of a Pharmaceutical Firm

   • Danny Cassimon
   • Peter-Jan Engelen
   • Vilimir Yordanov

   Current Opinion 24 August 2012 Pages: 87 - 97

   

3. Product Pipelines and Pharmaceutical Risk Management in the New Era of Strict Regulatory Scrutiny

   • William K. Sietsema

   Leading Article 24 August 2012 Pages: 99 - 106

   

4. Embryonic Stem Cells

   • Gabriela Gebrin Cezar

   Review Article 24 August 2012 Pages: 107 - 114

5. Estimation of the Quality of Clinical Trials from GCP Audit Findings in Japan

   • Kazuyuki Saito
   • Yasuo Kodama
   • Etsuko Miyamoto

   Original Research Article 24 August 2012 Pages: 115 - 119

   

6. The 28th Annual San Antonio Breast Cancer Symposium (SABCS)

   • Melanie Sweetlove
   • Michelle Wilde

   Meeting Report 24 August 2012 Pages: 121 - 123

7. Forum

   Update 24 August 2012 Pages: 125 - 130

8. Summary of Recent Deal Activity

   Update 24 August 2012 Pages: 131 - 140

   

9. Major Pharmaceutical Conferences

   Update 24 August 2012 Pages: 141 - 142

   

10. Society of Pharmaceutical Medicine

    SPM News 24 August 2012 Pages: 143 - 144

    

11. Directory

    BriefCommunication 24 August 2012 Pages: 145 - 147